Showing results for "Neurocrine"
business
AbbVie Gets OK for Potential Blockbuster Endometriosis TreatmentAbbVie Inc. won U.S. approval for an oral medicine that treats pain caused by the gynecological disorder endometriosis, a step toward giving the maker of the blockbuster arthritis treatment Humira another potential billion-dollar sales hit.July 24, 2018